Website stats for Genentech-access - genentech-access.com
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy of the information contained on sites we do not own or control. Genentech does not recommend and does not endorse the content on any third-party websites. Your use of third-party websites is at your own risk and subject to...
genentech-access.com was registered 1 decade 2 years ago. It has a alexa rank of #1,231,066 in the world. It is a domain having .com extension. It is estimated worth of $ 960.00 and have a daily income of around $ 4.00. As no active threats were reported recently, genentech-access.com is SAFE to browse.
Traffic Report
| Daily Unique Visitors: | 712 |
| Daily Pageviews: | 1,424 |
Estimated Valuation
| Income Per Day: | $ 4.00 |
| Estimated Worth: | $ 960.00 |
Search Engine Indexes
| Google Indexed Pages: | Not Applicable |
| Yahoo Indexed Pages: | Not Applicable |
| Bing Indexed Pages: | Not Applicable |
Search Engine Backlinks
| Google Backlinks: | Not Applicable |
| Bing Backlinks: | Not Applicable |
| Alexa BackLinks: | Not Applicable |
Safety Information
| Google Safe Browsing: | No Risk Issues |
| Siteadvisor Rating: | Not Applicable |
| WOT Trustworthiness: |
 Very Poor
|
| WOT Privacy: |
Very Poor
|
| WOT Child Safety: |
Very Poor
|
Website Ranks & Scores
| Alexa Rank: | 1,231,066 |
| PageSpeed Score: | 62 ON 100 |
| Domain Authority: |
49 ON 100 
|
| Bounce Rate: | Not Applicable |
| Time On Site: | Not Applicable |
Web Server Information
Hosted IP Address:
72.34.128.158
Hosted Country:
US
Location Latitude:
38.3566Location Longitude:
-121.988Traffic Classification
| Total Traffic: | No Data |
| Direct Traffic: | No Data |
| Referral Traffic: | No Data |
| Search Traffic: | No Data |
| Social Traffic: | No Data |
| Mail Traffic: | No Data |
| Display Traffic: | No Data |
Search Engine Results For genentech-access.com
Genentech Access Solutions | Health Care Professionals
The link you have selected will take you away from this site to one that is not owned or controlled by Genentech, Inc. Genentech, Inc. makes no representation as to the accuracy...
Genentech: Financial Support
Genentech takes the health and safety of our patients, customers, employees and local communities very seriously, and we are actively responding to the global COVID-19 pandemic.
RITUXAN® (rituximab) Patient Financial Assistance
RITUXAN Patient Assistance Programs. Genentech Access Solutions ® —Connecting patients to RITUXAN. Even if you have health insurance, you might feel concerned about the cost of...
My Patient Solutions - Login
My Patient Solutions ®. My Patient Solutions is an online tool to help you enroll and manage your Genentech Access Solutions service requests. It allows you the flexibility to...
Genentech Access Solutions | Rituxan® (rituximab) GPA & MPA
Tumor Lysis Syndrome (TLS): Acute renal failure, hyperkalemia, hypocalcemia, hyperuricemia, or hyperphosphatemia from tumor lysis, sometimes fatal, can occur within 12-24 hours...
Genentech Access to Care Foundation (Xolair) - Patient ...
Summary. Genentech, Inc. was founded in 1976 by Robert A. Swanson and Dr. Herbert W. Boyer. The company is primarily based around the field of recombinant DNA technology that...
Genentech Pro | CATHFLO® ACTIVASE® (alteplase)
For a list of sample codes for Cathflo, visit Genentech-Access.com. How do I learn about financial assistance options for my eligible patients? For spoiled product, please...
Financial Assistance & Copay Information | Esbriet ...
COMMITTED TO HELPING YOU FIND ASSISTANCE OPTIONS FOR ESBRIET Find out what your insurance covers and where to get extra assistance. Genentech Access Solutions is a program that...
Log in to Your Account - Lucentis
Who is LUCENTIS for? LUCENTIS ® (ranibizumab injection) is a prescription medicine for the treatment of patients with wet age-related macular degeneration (wAMD), macular edema...
Patient Access Solutions | LUCENTIS® (ranibizumab injection)
Your Patient Might Qualify for a Referral to an Independent Co-pay Assistance Foundation. For eligible patients with commercial or public health insurance, LUCENTIS Access...
A New Treatment for HER2 Positive Breast Cancer | PHESGO™
Introducing PHESGO—a new option that combines PERJETA ® (pertuzumab) and Herceptin ® (trastuzumab) in a single ~ 5 minute injection* With PHESGO, part of your HER2+ breast...
XOLAIR Co-pay Program
What is XOLAIR? XOLAIR ® (omalizumab) for subcutaneous use is an injectable prescription medicine used to treat:. moderate to severe persistent asthma in patients 6 years of age...
OCREVUS® (ocrelizumab) | Multiple Sclerosis (MS) Treatment
Learn about OCREVUS® (ocrelizumab), a prescription medicine used to treat adults with relapsing or primary progressive multiple sclerosis. See full safety for more information.
Patient Assistance & Cost Support | Pulmozyme® (dornase alfa)
You Might Qualify for a Referral to the Genentech Patient Foundation. The Genentech Patient Foundation provides free Genentech medicine to people who don't have insurance...
Genentech Access Solutions - force.com
Main website: www.genentech-access.com General inquiries, comments and feedback including technical issues involving the Access Solutions websites can be emailed to...
XOLAIR Allergic Asthma Financial Support Options | XOLAIR ...
Find out if you qualify for XOLAIR (omalizumab) for subcutaneous use financial support options that may help you cover the cost of your allergic asthma treatment. See full...
Page Resources Breakdown
Homepage Links Analysis
Website Inpage Analysis
| H1 Headings: | 2 | H2 Headings: | 5 |
| H3 Headings: | 3 | H4 Headings: | 4 |
| H5 Headings: | Not Applicable | H6 Headings: | Not Applicable |
| Total IFRAMEs: | Not Applicable | Total Images: | 13 |
| Google Adsense: | Not Applicable | Google Analytics: | Not Applicable |
HTTP Header Analysis
Status-Code: 200
Status: 200 OK
Accept-Ranges: bytes
Content-Encoding: gzip
Content-Type: text/html; charset=UTF-8
Date: Thu, 22 Aug 2019 08:17:16 GMT
Server: Apache
Vary: Accept-Encoding
Content-Length: 7951
Connection: keep-alive
Domain Information
| Domain Registrar: |
SafeNames Ltd.
|
|---|---|
| Registration Date: | 2012-04-27 1 decade 2 years 5 months ago |
| Last Modified: | 2018-05-01 6 years 5 months 5 days ago |
Domain Nameserver Information
| Host | IP Address | Country | |
|---|---|---|---|
| dnadns2e.gene.com | |
72.34.128.76 | United States |
| dnadns3e.gene.com | |
72.34.133.50 | United States |
| dnadns4e.gene.com | |
72.34.128.50 | United States |
DNS Record Analysis
| Host | Type | TTL | Extra |
|---|---|---|---|
| genentech-access.com | A | 3583 |
IP: 72.34.128.158 |
| genentech-access.com | NS | 86400 |
Target: dnadns3e.gene.com |
| genentech-access.com | NS | 86400 |
Target: dnadns2e.gene.com |
| genentech-access.com | NS | 86400 |
Target: dnadns4e.gene.com |
| genentech-access.com | SOA | 3600 |
MNAME: bc-dns-ext-mstr.gene.com RNAME: postmaster.no.email.please Serial: 559733277 Refresh: 3600 Retry: 600 Expire: 2592000 |
| genentech-access.com | MX | 3600 |
Priority: 10 Target: smtaextvv01.gene.com |
| genentech-access.com | MX | 3600 |
Priority: 10 Target: smtaextrwc01.gene.com |
Full WHOIS Lookup
Registry Domain ID:
1716343890_DOMAIN_COM-VRSN
Registrar WHOIS Server:
whois.safenames.net
Registrar URL:
http://www.safenames.net
Updated Date:
2018-05-01T11:06:27Z
Creation Date:
2012-04-27T06:00:35Z
Registry Expiry Date:
2020-04-27T06:00:35Z
Registrar: SafeNames Ltd.
Registrar IANA
ID: 447
Registrar Abuse Contact Email:
[email protected]
Registrar Abuse Contact Phone:
+44.1908200022
Domain Status: clientDeleteProhibited
https://icann.org/epp#clientDeleteProhibited
Domain Status:
clientTransferProhibited
https://icann.org/epp#clientTransferProhibited
Domain Status:
clientUpdateProhibited
https://icann.org/epp#clientUpdateProhibited
Name Server:
DNADNS2E.GENE.COM
Name Server: DNADNS3E.GENE.COM
Name Server:
DNADNS4E.GENE.COM
DNSSEC: unsigned
URL of the ICANN Whois
Inaccuracy Complaint Form: https://www.icann.org/wicf/
>>> Last
update of whois database: 2019-08-22T08:17:25Z
Similarly Ranked Websites
Max Lucado - Best-selling Christian Author of Anxious for Nothing
Home of best-selling Christian author Max Lucado. Author of Anxious for Nothing, 3:16, You'll Get through This, Facing Your Giants, and Unshakeable Hope.
1,231,073 
$ 960.00
College moving, storage & shipping made simple | Dorm Room Movers
1,231,080 $ 960.00
Boostrap - Twitter Bootstrap To Most People
Twitter bootstrap resource site with links to top bootstrap sites
1,231,085 $ 960.00
Usuario Linux | El Software Libre
La distribución Deepin ha llamado la atención de muchos usuarios, teniendo mucho repunte exitoso Linux con su nueva versión. Cuenta con nuevas características,
1,231,087 $ 960.00
bikehike.co.uk - Home
Create or view courses on Google or Ordnance Survey maps
1,231,087 $ 960.00